Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Jones

Showing results (431-440 of 457) with videos related to

Pageof 46
Sort By:
Eclinicalmedicine|October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyChristopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
MMWR. Morbidity and Mortality Weekly Report|January 3, 2020
Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge - United States, December 2019Mary E Evans, Evelyn Twentyman, Eleanor S Click, et al.
Journal of Substance Use and Addiction Treatment|July 1, 2026
Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health toolsLuke C Hall, Julie M Donohue, Marc LaRochelle, et al.
JAMA Pediatrics|May 19, 2020
Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) in the United States in 2019Susan H Adkins, Kayla N Anderson, Alyson B Goodman, et al.
Frontiers in Epidemiology|May 3, 2024
Different clinical characteristics and outcomes of adult hospitalized SARS-CoV-2 pneumonia patients complicated by cardiovascular events during the first, delta and omicron waves of COVID-19Lynn P Roser, Harideep Samanapally, T'shura Ali, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
MMWR. Morbidity and Mortality Weekly Report|October 22, 2019
Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019David A Siegel, Tara C Jatlaoui, Emily H Koumans, et al.
Transplantation|June 17, 2020
The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020Jonathan Bromberg, Carla Baan, Jeremy Chapman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
MMWR. Morbidity and Mortality Weekly Report|November 15, 2019
Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019Benjamin C Blount, Mateusz P Karwowski, Maria Morel-Espinosa, et al.
Pageof 46

Showing results (431-440 of 457) with videos related to

Sort By:
Pageof 46
Eclinicalmedicine|October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyChristopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
MMWR. Morbidity and Mortality Weekly Report|January 3, 2020
Update: Interim Guidance for Health Care Professionals Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury and for Reducing the Risk for Rehospitalization and Death Following Hospital Discharge - United States, December 2019Mary E Evans, Evelyn Twentyman, Eleanor S Click, et al.
Journal of Substance Use and Addiction Treatment|July 1, 2026
Methodological innovations to advance substance use disorder research: Proceedings of a NIDA workshop on target trial emulation and translational testing of digital health toolsLuke C Hall, Julie M Donohue, Marc LaRochelle, et al.
JAMA Pediatrics|May 19, 2020
Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) in the United States in 2019Susan H Adkins, Kayla N Anderson, Alyson B Goodman, et al.
Frontiers in Epidemiology|May 3, 2024
Different clinical characteristics and outcomes of adult hospitalized SARS-CoV-2 pneumonia patients complicated by cardiovascular events during the first, delta and omicron waves of COVID-19Lynn P Roser, Harideep Samanapally, T'shura Ali, et al.
BMC Cancer|June 29, 2026
Pre-operative proton versus photon-based chemoradiotherapy as an addition to best systemic therapy in the management of oesophageal cancer: protocol for the UK multi-centre randomised phase 2 PROTIEUS studyGanesh Radhakrishna, Christopher M Jones, C William Bleaney, et al.
MMWR. Morbidity and Mortality Weekly Report|October 22, 2019
Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019David A Siegel, Tara C Jatlaoui, Emily H Koumans, et al.
Transplantation|June 17, 2020
The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020Jonathan Bromberg, Carla Baan, Jeremy Chapman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2024
Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: The phase 1/randomised phase 2 SCALOP-2 trialSomnath Mukherjee, Cathy Qi, Rachel Shaw, et al.
MMWR. Morbidity and Mortality Weekly Report|November 15, 2019
Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019Benjamin C Blount, Mateusz P Karwowski, Maria Morel-Espinosa, et al.
Pageof 46